Dr. Alexander Kolevzon, MD

Bio

Dr. Kolevzon serves as Clinical Director of Mount Sinai’s Seaver Autism Center and an Associate Professor at Icahn School of Medicine at Mount Sinai.

Dr. Kolevzon has published numerous papers on autism as well as three books designed for medical student and resident education. He has extensive clinical expertise in the psychopharmacology of autism and related conditions and his research is focused on developing new pharmacological treatments as an investigator on many clinical trials. He is also extremely committed to medical student and residency training and education and is the Associate Residency Training Director in Child and Adolescent Psychiatry at Mount Sinai. He is an active teacher, mentor, and clinical supervisor and has received many teaching awards as well as a grant to support innovative educational endeavors.


Specialties:

  • neurology

Affiliation:

  • The Mount Sinai Medical Center, Icahn School of Medicine at Mount Sinai

Location:

Activity

  • Sharecare News
    Sharecare News posted a story about Neurology:

    FRIDAY, May 17 (HealthDay News) -- New research suggests the dominant side of your brain may make the call on which ear you choose to use while talking on your cellphone.

    The dominant side of your brain is where your speech and language center resides. Ninety-five percent of the human pop...Full Article

  • Alexander Kolevzon, MD
    What does brain imaging show in people with autism?
    Over the last 20 years, neuroimaging studies have made great contributions to our understanding of...  Full Post
  • Alexander Kolevzon, MD
    What is the difference between autism and Asperger's syndrome?
    Asperger syndrome is distinguished from autism by the absence of intellectual disability or...  Full Post
  • Alexander Kolevzon, MD
    What are autism spectrum disorders?
    The Autism Spectrum encompasses a heterogeneous group of disorders that have traditionally been...  Full Post
  • Alexander Kolevzon, MD
    What are signs of autism in children?
    The Autism Spectrum encompasses a heterogeneous group of disorders that have traditionally been...  Full Post
  • Alexander Kolevzon, MD
    How common is autism?
    Autism spectrum disorders are characterized by social and language impairments in addition to...  Full Post
  • Sharecare News
    Sharecare News posted a story about Neurology:

    MONDAY, Aug. 13 (HealthDay News) -- A condition known as leukoaraiosis alters brain function in older people, according to a small new study.

    Contrary to past belief, researchers found this common condition, in which diseased blood vessels lead to small areas of...Full Article

  • Sharecare News
    Sharecare News posted a story about Neurology:

    FRIDAY, Aug. 10 (HealthDay News) -- Although they are common and often debilitating, migraine headaches are not associated with declines in thinking skills, researchers say.

    "Previous studies on migraines and cognitive [brain] decline were small and unable to identify a link between the t...Full Article

  • Alexander Kolevzon, MD
    Is there any new treatment in the pipeline for autism?
    There are several new treatments in the pipeline for autism spectrum disorder. Curemark, LLC recently released positive results from a phase 3 clinical trial of their compound, Luminenz, that is focused on treating symptoms of hyperactivity in Autism. Seaside Therapeutics is also studying Arba...  Full Post